CAS No. 168434-28-4
Spiro[3H-[1,3]dioxolo[5,6]indeno[2,1-c]isoxazole-3,1'(3'H)-isobenzofuran]-3'-one,1,3a,9,9a-tetrahydro-4',5'-dimethoxy-1-methyl-, (3a,3ab,9ab)-
Spiro[3H-[1,3]dioxolo[5,6]indeno[2,1-c]isoxazole-3,1'(3'H)-isobenzofuran]-3'-one,1,3a,9,9a-tetrahydro-4',5'-dimethoxy-1-methyl-, (3a,3ab,9ab)-Identification
| Catalog number | 596425 |
| Chemical name | Spiro[3H-[1,3]dioxolo[5,6]indeno[2,1-c]isoxazole-3,1'(3'H)-isobenzofuran]-3'-one,1,3a,9,9a-tetrahydro-4',5'-dimethoxy-1-methyl-, (3a,3ab,9ab)- |
| CAS RN | 168434-28-4 |
| Molecular formula | C21H19NO7 |
Structure
About Spiro[3H-[1,3]dioxolo[5,6]indeno[2,1-c]isoxazole-3,1'(3'H)-isobenzofuran]-3'-one,1,3a,9,9a-tetrahydro-4',5'-dimethoxy-1-methyl-, (3a,3ab,9ab)-
Spiro[3H-[1,3]dioxolo[5,6]indeno[2,1-c]isoxazole-3,1'(3'H)-isobenzofuran]-3'-one,1,3a,9,9a-tetrahydro-4',5'-dimethoxy-1-methyl-, (3a,3ab,9ab)- is a chemical compound registered under CAS number 168434-28-4, with the molecular formula C21H19NO7 and a molecular weight of about 397.38 g/mol. It is also known as Dactylicapnosinine. ChemToDo supplies Spiro[3H-[1,3]dioxolo[5,6]indeno[2,1-c]isoxazole-3,1'(3'H)-isobenzofuran]-3'-one,1,3a,9,9a-tetrahydro-4',5'-dimethoxy-1-methyl-, (3a,3ab,9ab)- for laboratory research and bulk production; product code 596425. Send an inquiry for purity, packaging, price and lead time.
- CAS Number
- 168434-28-4
- Molecular Formula
- C21H19NO7
- Molecular Weight
- 397.38 g/mol
Synonyms
- Dactylicapnosinine
1-(Dimethylamino)-1,2,3,4,4a,5,6,8a-octahydro-α,α,4a,8a-tetramethyl-2-naphthalenemethanol
56701-22-5
Decanoic acid, 9-oxo-, cyclic 1,2-ethanediyl acetal
4388-49-2
Ethanesulfonic acid, 2-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-
439088-67-2
Carbamic acid,[5-(1H-benzimidazol-2-ylsulfonyl)-1H-benzimidazol-2-yl]-, methyl ester
89028-99-9
3-Furanpropanol, a-(1-methylethenyl)-
56694-87-2
D-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-, anhydride
89028-47-7
Urea, N-hydroxy-N-(1-methyl-2-propynyl)-, (R)-
(S)-2-Methylbutanoic acid [(3R,10R)-10-acetoxy-5aβ-acetoxymethyl-6β,7β-bis(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-9α-hydroxy-2,2,9-trimethyl-2H-3β,9aβ-methano-1-benzoxepin-5α-yl] ester
Arcitumomab
2-Naphthalenesulfonic acid, 4-hydroxy-6-[(4-nitro-2-sulfophenyl)amino]-